Latest TWST news

3 Analysts, 3 Trades to Make Today

InvestorPlace · Tue, 22 Sep 2026 17:00:00 -0400

On any given day, there's a headline, a fear, or a worry screaming for your attention. We regularly cover those headlines here, doing our best to separate the signal from the noise so you can keep moving toward your financial goals.

Why Twist Bioscience Stock Skyrocketed This Week

The Motley Fool · Fri, 18 Sep 2026 19:36:28 -0400

The biotech will both contribute to and draw from its findings. It'll also earn revenue from its participation.

Beyond Hype: Twist Bioscience Secures Data Pipeline Role In Eli Lilly TuneLab Ecosystem

Benzinga · Wed, 16 Sep 2026 10:59:31 -0400

Twist Bioscience Corporation (NASDAQ:TWST) on Wednesday announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Co. (NYSE:LLY).

LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday

Benzinga · Wed, 16 Sep 2026 09:57:46 -0400

U.S. stocks were mixed, with the Nasdaq Composite gaining around 150 points on Wednesday.

Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery

Business Wire · Wed, 16 Sep 2026 08:00:00 -0400

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). Twist is a provider of antibody characterization data services for TuneLab, including for AbLab, an antibody developability prediction model. TuneLab was created to accelerate biotech innovation by enabling participating compan.

AI & Robotics in 2026: 16 Recent Developments for Investors

ETF Trends · Wed, 09 Sep 2026 11:34:29 -0400

If AI and robotics suddenly feel like they are moving faster, August gave investors plenty of evidence that the pace really is accelerating. We saw longer-running agents, faster and cheaper inference, AI systems reaching into laboratories and physical equipment, robots learning from fewer demonstrations, and new capital and infrastructure forming around commercial deployment.

Twist Bioscience to Present at Baird 2026 Global Healthcare Conference

Business Wire · Wed, 09 Sep 2026 08:00:00 -0400

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of Twist Bioscience, will participate in a fireside chat at the Baird 2026 Global Healthcare Conference on Tuesday, September 15, 2026 at 1:25 pm Eastern Time in New York City. The fireside chat will be webcast live and can be accessed by visiting the “In.

Market information is provided for research and visualization and is not investment advice.